Ozempic keeps wowing: trial data show benefits for kidney disease

Nature. 2024 Jun;630(8015):16-17. doi: 10.1038/d41586-024-01564-w.
No abstract available

Keywords: Diseases; Medical research; Obesity; Public health; Research data.

Publication types

  • News

MeSH terms

  • Clinical Trials as Topic*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / mortality
  • Glucagon-Like Peptides* / therapeutic use
  • Humans
  • Kidney Diseases* / drug therapy
  • Kidney Diseases* / etiology
  • Kidney Diseases* / mortality

Substances

  • semaglutide
  • Glucagon-Like Peptides